首页> 外国专利> Inactivating expression of selected protein or RNA in cells comprises integrating a sequence into transcript of selected protein or RNA which acts as target for interfering RNA

Inactivating expression of selected protein or RNA in cells comprises integrating a sequence into transcript of selected protein or RNA which acts as target for interfering RNA

机译:使所选蛋白质或RNA在细胞中的表达失活包括将序列整合到所选蛋白质或RNA的转录本中,以作为干扰RNA的靶标

摘要

Inactivating expression of a selected protein or RNA in a cell, in vitro or ex vivo comprises: (A) introducing into the cell a vector (V1) that contains (i) a nucleic acid (A) encoding the protein or RNA and (ii) at least two copies of a sequence (B) of at least 10 nucleotides, so that during transcription, B makes up part of the transcript containing A but does not make up part of the coding sequence comprising A; and (B) introducing into the cell a second vector (V2) that causes synthesis of an interfering RNA (iRNA) that targets B. Independent claims are also included for the following: (1) combination of V1 and V2; (2) vector (V3) comprising a multiple cloning site for insertion of A and at least 2 copies of B; (3) vector (V4) containing A and at least two copies of B so that during transcription B makes up part of the 3'-UTR (untranslated region) of the A-containing transcript; (4) viral particles comprising V3 or V4, where these are viral vectors; (5) kit for expressing a protein or RNA, and for its inactivation, comprising V1 and V2; and (6) genetically modified cell containing in its genome an exogenous transgene that includes, in its 3'-UTR, at least two copies of B, optionally also a sequence that produces iRNA.
机译:在体外或离体细胞中失活所选蛋白质或RNA的表达包括:(A)将包含(i)编码该蛋白质或RNA的核酸(A)的载体(V1)引入细胞中(V1) )至少十个核苷酸的序列(B)的至少两个拷贝,因此在转录过程中,B构成包含A的转录本的一部分,但不构成包含A的编码序列的一部分; (1)V1和V2的组合;和(B)将引起靶向B的干扰RNA(iRNA)合成的第二载体(V2)引入细胞。 (2)载体(V3),其包含用于插入A和至少2个拷贝的B的多个克隆位点; (3)载体(V4),其含有A和至少两个拷贝的B,从而在转录过程中B构成了含A转录物的3'-UTR(非翻译区)的一部分; (4)包含V3或V4的病毒颗粒,其中这些是病毒载体; (5)用于表达蛋白质或RNA并使其灭活的试剂盒,其包含V1和V2; (6)基因改造的细胞,其基因组中含有外源转基因,该外源转基因在其3'-UTR中包括至少两个拷贝的B,任选地还包含产生iRNA的序列。

著录项

  • 公开/公告号FR2872171A1

    专利类型

  • 公开/公告日2005-12-30

    原文格式PDF

  • 申请/专利权人 APTANOMICS SOCIETE ANONYME;

    申请/专利号FR20040006931

  • 发明设计人 MANGEOT PHILIPPE EMMANUEL;MIKAELIAN IVAN;

    申请日2004-06-24

  • 分类号C12N15/00;A61K48/00;C12N15/63;C12N15/86;C12Q1/68;

  • 国家 FR

  • 入库时间 2022-08-21 21:17:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号